Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 298

1.

Performance of a modified three-level classification in stratifying open liver resection procedures in terms of complexity and postoperative morbidity.

Kawaguchi Y, Hasegawa K, Tzeng CD, Mizuno T, Arita J, Sakamoto Y, Chun YS, Aloia TA, Kokudo N, Vauthey JN.

Br J Surg. 2019 Oct 11. doi: 10.1002/bjs.11351. [Epub ahead of print]

PMID:
31603540
2.

Characteristics of atypical large well-differentiated hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma?

Okuno M, Newhook TE, Joechle K, Kawaguchi Y, De Bellis M, Tzeng CD, Chun YS, Aloia TA, Shindoh J, Kaseb AO, Vauthey JN.

HPB (Oxford). 2019 Sep 16. pii: S1365-182X(19)30702-6. doi: 10.1016/j.hpb.2019.08.012. [Epub ahead of print]

PMID:
31533893
3.

Opioid-Prescribing Practices After Oncologic Surgery: Opportunities for Improvement and a Call to Action.

Newhook TE, Vreeland TJ, Dewhurst WL, Arvide EM, Bruno ML, Robinson KA, Rajkot N, Aloia TA, Katz MHG, Vauthey JN, Lee JE, Tzeng CD.

Ann Surg. 2019 Aug 29. doi: 10.1097/SLA.0000000000003595. [Epub ahead of print] No abstract available.

PMID:
31478982
4.

Staging of Biliary and Primary Liver Tumors: Current Recommendations and Workup.

Krampitz GW, Aloia TA.

Surg Oncol Clin N Am. 2019 Oct;28(4):663-683. doi: 10.1016/j.soc.2019.06.007. Review.

PMID:
31472912
5.

Enhanced recovery program implementation: an evidence-based review of the art and the science.

Aloia TA, Keller DS, Kowalski RB, Lin H, Luciano MM, Myers JA, Sinha P, Spaniolas K, Young-Fadok TM.

Surg Endosc. 2019 Aug 26. doi: 10.1007/s00464-019-07065-6. [Epub ahead of print]

PMID:
31451916
6.

Validation of Laser Capture Microdissection Protocol in Endometriosis Studies.

da Costa KA, Malvezzi H, Viana BG, Filippi RZ, Neme RM, Aloia TPA, Podgaec S, Piccinato CA.

Medicina (Kaunas). 2019 Aug 22;55(9). pii: E520. doi: 10.3390/medicina55090520.

7.

Using Center-Specific Medicare Data to Compare Cancer Care Outcomes: Are We Seeing the Whole Playing Field or Just a Blade of Grass.

Aloia TA.

Ann Surg Oncol. 2019 Nov;26(12):3809-3810. doi: 10.1245/s10434-019-07720-1. Epub 2019 Aug 16. No abstract available.

PMID:
31420801
8.

Severe Preoperative Symptoms Delay Readiness to Return to Intended Oncologic Therapy (RIOT) After Liver Resection.

Lillemoe HA, Marcus RK, Kim BJ, Narula N, Davis CH, Shi Q, Wang XS, Aloia TA.

Ann Surg Oncol. 2019 Aug 14. doi: 10.1245/s10434-019-07719-8. [Epub ahead of print]

PMID:
31414293
9.

Postoperative Urinary Tract Infection Quality Assessment and Improvement: The S.T.O.P. UTI Program and Its Impact on Hospitalwide CAUTI Rates.

Narula N, Lillemoe HA, Caudle AS, Chemaly RF, Anderson JJ, Segal C, Porter CA, Swisher SG, Levenback CF, Aloia TA.

Jt Comm J Qual Patient Saf. 2019 Oct;45(10):686-693. doi: 10.1016/j.jcjq.2019.06.001. Epub 2019 Jul 29.

PMID:
31371099
10.

Inpatient Opioid Use After Pancreatectomy: Opportunities for Reducing Initial Opioid Exposure in Cancer Surgery Patients.

Newhook TE, Dewhurst WL, Vreeland TJ, Wang X, Soliz J, Speer BB, Hancher-Hodges S, Feng C, Bruno ML, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MHG, Tzeng CD.

Ann Surg Oncol. 2019 Oct;26(11):3428-3435. doi: 10.1245/s10434-019-07528-z. Epub 2019 Jun 26.

PMID:
31243665
11.

Preoperative PET/CT does not accurately detect extrauterine disease in patients with newly diagnosed high-risk endometrial cancer: A prospective study.

Stewart KI, Chasen B, Erwin W, Fleming N, Westin SN, Dioun S, Frumovitz M, Ramirez PT, Lu KH, Wong F, Aloia TA, Soliman PT.

Cancer. 2019 Oct 1;125(19):3347-3353. doi: 10.1002/cncr.32329. Epub 2019 Jun 21.

PMID:
31225906
12.

Mutation Status of RAS, TP53, and SMAD4 is Superior to Mutation Status of RAS Alone for Predicting Prognosis after Resection of Colorectal Liver Metastases.

Kawaguchi Y, Kopetz S, Newhook TE, De Bellis M, Chun YS, Tzeng CD, Aloia TA, Vauthey JN.

Clin Cancer Res. 2019 Oct 1;25(19):5843-5851. doi: 10.1158/1078-0432.CCR-19-0863. Epub 2019 Jun 20.

PMID:
31221662
13.

Benefit of Gemcitabine/Nab-Paclitaxel Rescue of Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma After Early Failure of FOLFIRINOX.

Vreeland TJ, McAllister F, Javadi S, Prakash LR, Fogelman DR, Ho L, Varadhachary G, Aloia TA, Vauthey JN, Lee JE, Kim MP, Katz MHG, Tzeng CD.

Pancreas. 2019 Jul;48(6):837-843. doi: 10.1097/MPA.0000000000001345.

PMID:
31210666
14.

Complex General Surgical Oncology Fellowship Applicants: Trends over Time and the Impact of Board Certification Eligibility.

Lillemoe HA, Scally CP, Adams CL, Bednarski BK, Balch CM, Aloia TA, Gershenwald JE, Lee JE, Grubbs EG.

Ann Surg Oncol. 2019 Sep;26(9):2667-2674. doi: 10.1245/s10434-019-07420-w. Epub 2019 Jun 5.

PMID:
31168736
15.

Public reporting and transparency: a primer on public outcomes reporting.

Romanelli JR, Fuchshuber PR, Stulberg JJ, Kowalski RB, Sinha P, Aloia TA, Orlando R 3rd.

Surg Endosc. 2019 Jul;33(7):2043-2049. doi: 10.1007/s00464-019-06756-4. Epub 2019 Jun 3.

PMID:
31161288
16.

Enhanced recovery in liver surgery decreases postoperative outpatient use of opioids.

Lillemoe HA, Marcus RK, Day RW, Kim BJ, Narula N, Davis CH, Gottumukkala V, Aloia TA.

Surgery. 2019 Jul;166(1):22-27. doi: 10.1016/j.surg.2019.02.008. Epub 2019 May 15.

PMID:
31103198
17.

Intraoperative Air Leak Test to Prevent Bile Leak After Right Posterior Sectionectomy with En Bloc Diaphragm Resection for Metastatic Teratoma.

Vreeland TJ, Beaudry Simoneau E, Dewhurst WL, Newhook TE, Westin SN, Mehran RJ, Chun YS, Aloia TA, Vauthey JN, Tzeng CD.

Ann Surg Oncol. 2019 Aug;26(8):2579. doi: 10.1245/s10434-019-07410-y. Epub 2019 May 7.

PMID:
31065963
18.

Conditional Recurrence-Free Survival after Resection of Colorectal Liver Metastases: Persistent Deleterious Association with RAS and TP53 Co-Mutation.

Kawaguchi Y, Lillemoe HA, Panettieri E, Chun YS, Tzeng CD, Aloia TA, Kopetz S, Vauthey JN.

J Am Coll Surg. 2019 Sep;229(3):286-294.e1. doi: 10.1016/j.jamcollsurg.2019.04.027. Epub 2019 May 2.

PMID:
31054911
19.

Should Zero Harm Be Our Goal?

Aloia TA.

Ann Surg. 2019 Apr 8. doi: 10.1097/SLA.0000000000003316. [Epub ahead of print]

PMID:
30973390
20.

Facilitation of Surgical Innovation: Is It Possible to Speed the Introduction of New Technology While Simultaneously Improving Patient Safety?

Marcus RK, Lillemoe HA, Caudle AS, Weinberg JS, Gidley PW, Skibber JM, Levenback CF, Swisher SG, Aloia TA.

Ann Surg. 2019 Mar 26. doi: 10.1097/SLA.0000000000003290. [Epub ahead of print]

PMID:
30946086
21.

Educating Surgical Oncology Providers on Perioperative Opioid Use: Results of a Departmental Survey on Perceptions of Opioid Needs and Prescribing Habits.

Lillemoe HA, Newhook TE, Vreeland TJ, Arvide EM, Dewhurst WL, Grubbs EG, Aloia TA, Vauthey JN, Lee JE, Tzeng CD.

Ann Surg Oncol. 2019 Jul;26(7):2011-2018. doi: 10.1245/s10434-019-07321-y. Epub 2019 Apr 1.

PMID:
30937660
22.

Comparative Effectiveness of Computed Tomography- Versus Ultrasound-Guided Percutaneous Radiofrequency Ablation Among Medicare Patients 65 Years of Age or Older With Hepatocellular Carcinoma.

Huo J, Aloia TA, Xu Y, Chung TH, Sheu T, Tina Shih YC.

Value Health. 2019 Mar;22(3):284-292. doi: 10.1016/j.jval.2018.10.004. Epub 2018 Nov 27.

PMID:
30832966
23.

Detours on the Road to Recovery: What Factors Delay Readiness to Return to Intended Oncologic Therapy (RIOT) After Liver Resection for Malignancy?

Lillemoe HA, Marcus RK, Kim BJ, Narula N, Davis CH, Aloia TA.

J Gastrointest Surg. 2019 Feb 26. doi: 10.1007/s11605-019-04165-5. [Epub ahead of print]

PMID:
30809785
24.

Enhanced recovery in liver surgery.

Day RW, Aloia TA.

J Surg Oncol. 2019 Apr;119(5):660-666. doi: 10.1002/jso.25420. Epub 2019 Feb 25. Review.

PMID:
30802314
25.

Is early-stage pancreatic adenocarcinoma truly early: stage migration on final pathology with surgery-first versus neoadjuvant therapy sequencing.

Lee AJ, Simoneau E, Chiang YJ, Lee JE, Kim MP, Aloia TA, Vauthey JN, Katz MH, Tzeng CD.

HPB (Oxford). 2019 Sep;21(9):1203-1210. doi: 10.1016/j.hpb.2019.01.011. Epub 2019 Feb 22.

PMID:
30799277
26.

Setting the "stage" for Surgical Oncology fellows: Pierre Denoix and TNM staging.

Asare EA, Grubbs EG, Gershenwald JE, Greene FL, Aloia TA.

J Surg Oncol. 2019 Jun;119(7):823. doi: 10.1002/jso.25404. Epub 2019 Feb 6. No abstract available.

PMID:
30729519
27.

Impact of epidural analgesia on the systemic biomarker response after hepatic resection.

Vicente D, Patino M, Marcus R, Lillmoe H, Limani P, Newhook T, Lee A, Tzeng CW, Segraves-Chun Y, Tweardy D, Gottumukkala V, Vauthey JN, Aloia T, Cata JP.

Oncotarget. 2019 Jan 15;10(5):584-594. doi: 10.18632/oncotarget.26549. eCollection 2019 Jan 15.

28.

Developing minimally invasive procedure quality metrics: one step at a time.

Aloia TA, Jackson T, Ghaferi A, Dort J, Schwarz E, Romanelli J.

Surg Endosc. 2019 Mar;33(3):679-683. doi: 10.1007/s00464-019-06661-w. Epub 2019 Jan 22.

PMID:
30671664
29.

Chemotherapy Versus Chemoradiation as Preoperative Therapy for Resectable Pancreatic Ductal Adenocarcinoma: A Propensity Score Adjusted Analysis.

Cloyd JM, Chen HC, Wang X, Tzeng CD, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MHG.

Pancreas. 2019 Feb;48(2):216-222. doi: 10.1097/MPA.0000000000001231.

PMID:
30629022
30.

Determining the Safety and Efficacy of Enhanced Recovery Protocols in Major Oncologic Surgery: An Institutional NSQIP Analysis.

Marcus RK, Lillemoe HA, Rice DC, Mena G, Bednarski BK, Speer BB, Ramirez PT, Lasala JD, Navai N, Williams WH, Kim BJ, Voss RK, Gottumukkala VN, Aloia TA.

Ann Surg Oncol. 2019 Mar;26(3):782-790. doi: 10.1245/s10434-018-07150-5. Epub 2019 Jan 9.

PMID:
30627879
31.

Continuous Quality Improvement Measured With Time-Driven Activity-Based Costing in an Outpatient Cancer Surgery Center.

French KE, Recinos I, Guzman AB, Aloia TA, Hernandez M, Kee SS, Kowalski AM, Goravanchi F, Cerny J, Cleckler-Hughes KV, Rebello E.

J Oncol Pract. 2019 Feb;15(2):e162-e168. doi: 10.1200/JOP.18.00394. Epub 2019 Jan 7.

PMID:
30615585
32.

Expansive Vascular Remodeling and Increased Vascular Calcification Response to Cholecalciferol in a Murine Model of Obesity and Insulin Resistance.

Carmo LS, Burdmann EA, Fessel MR, Almeida YE, Pescatore LA, Farias-Silva E, Gamarra LF, Lopes GH, Aloia TPA, Liberman M.

Arterioscler Thromb Vasc Biol. 2019 Feb;39(2):200-211. doi: 10.1161/ATVBAHA.118.311880.

PMID:
30580565
33.

Recovery of the Cholangiocytes After Ischemia and Reperfusion Injury: Ultra-Structural, Hystological and Molecular Assessment in Rats.

Aloia TPA, Cogliati B, Monteiro JM, Goldberg ACK, de Oliveira Salvalaggio PR.

J Clin Exp Hepatol. 2018 Dec;8(4):380-389. doi: 10.1016/j.jceh.2018.01.003. Epub 2018 Feb 11.

PMID:
30563999
34.

Contemporary analysis of complications associated with biliary stents during neoadjuvant therapy for pancreatic adenocarcinoma.

Kim BJ, Prakash L, Narula N, Davis CH, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MH, Tzeng CD.

HPB (Oxford). 2019 Jun;21(6):662-668. doi: 10.1016/j.hpb.2018.10.009. Epub 2018 Dec 3.

PMID:
30522947
35.

Pancreaticoduodenectomy with Mesocaval Shunt for Locally Advanced Pancreatic Adenocarcinoma.

Simoneau E, Goumard C, Lee JE, Vauthey JN, Aloia TA, Chun YS, Kim MP, Katz MHG, Tzeng CD.

Ann Surg Oncol. 2019 Feb;26(2):652. doi: 10.1245/s10434-018-07093-x. Epub 2018 Dec 11.

PMID:
30539487
36.

Perioperative blood transfusions for vein resection during pancreaticoduodenectomy for pancreatic adenocarcinoma: Identification of clinical targets for optimization.

Snyder RA, Prakash LR, Nogueras-Gonzalez GM, Kim MP, Aloia TA, Vauthey JN, Lee JE, Fleming JB, Katz MHG, Tzeng CD.

HPB (Oxford). 2019 Jul;21(7):841-848. doi: 10.1016/j.hpb.2018.10.018. Epub 2018 Nov 28.

PMID:
30501986
37.

Clinical Factors Associated With Practice Variation in Discharge Opioid Prescriptions After Pancreatectomy.

Newhook TE, Vreeland TJ, Dewhurst WL, Wang X, Prakash L, Feng C, Bruno ML, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MHG, Tzeng CD.

Ann Surg. 2018 Nov 29. doi: 10.1097/SLA.0000000000003112. [Epub ahead of print]

PMID:
30499795
38.

An Overview of Bundled Payments for Surgical Oncologists: Origins, Progress to Date, Terminology, and Future Directions.

Offodile AC 2nd, Mehtsun W, Stimson CJ, Aloia T.

Ann Surg Oncol. 2019 Jan;26(1):3-7. doi: 10.1245/s10434-018-7037-x. Epub 2018 Nov 8. No abstract available.

PMID:
30411272
39.

Current status and evolving treatment for primary liver cancers.

Zhu AX, Aloia TA.

Chin Clin Oncol. 2018 Oct;7(5):47. doi: 10.21037/cco.2018.10.05. No abstract available.

40.

Enhanced Recovery After Surgery: Hepatobiliary.

Lillemoe HA, Aloia TA.

Surg Clin North Am. 2018 Dec;98(6):1251-1264. doi: 10.1016/j.suc.2018.07.011. Epub 2018 Aug 24. Review.

PMID:
30390857
41.

Intrahepatic Recurrence Patterns Predict Survival After Resection of Colorectal Liver Metastases.

Lee AJ, Loyer EM, Kang HC, Aloia TA, Tzeng CD, Vauthey JN, Chun YS.

Ann Surg Oncol. 2019 Jan;26(1):275-281. doi: 10.1245/s10434-018-6945-0. Epub 2018 Oct 25.

PMID:
30362064
42.

Comprehensive Complication Index Validates Improved Outcomes Over Time Despite Increased Complexity in 3707 Consecutive Hepatectomies.

Cloyd JM, Mizuno T, Kawaguchi Y, Lillemoe HA, Karagkounis G, Omichi K, Chun YS, Conrad C, Tzeng CD, Odisio BC, Huang SY, Hicks M, Wei SH, Aloia TA, Vauthey JN.

Ann Surg. 2018 Oct 17. doi: 10.1097/SLA.0000000000003043. [Epub ahead of print]

PMID:
30339628
43.

The role of preoperative therapy prior to pancreatoduodenectomy for distal cholangiocarcinoma.

Cloyd JM, Prakash L, Vauthey JN, Aloia TA, Chun YS, Tzeng CW, Kim MP, Lee JE, Katz MHG.

Am J Surg. 2019 Jul;218(1):145-150. doi: 10.1016/j.amjsurg.2018.08.024. Epub 2018 Sep 6.

PMID:
30224070
44.

Loss of muscle mass during preoperative chemotherapy as a prognosticator for poor survival in patients with colorectal liver metastases.

Okuno M, Goumard C, Kopetz S, Vega EA, Joechle K, Mizuno T, Tzeng CD, Chun YS, Lee JE, Vauthey JN, Aloia TA, Conrad C.

Surgery. 2019 Feb;165(2):329-336. doi: 10.1016/j.surg.2018.07.031. Epub 2018 Sep 6.

PMID:
30197278
45.

Comment on Letter to the Editor Regarding "ALPPS Improves Resectability Compared With Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal Liver Metastasis: When Innovation is Not Enough".

Vega EA, Simoneau E, Tzeng CD, Odisio BC, Aloia TA, Chun YS, Vauthey JN.

Ann Surg. 2019 Aug;270(2):e35-e36. doi: 10.1097/SLA.0000000000003025. No abstract available.

PMID:
30169392
46.

Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma.

Elganainy D, Holliday EB, Taniguchi CM, Smith GL, Shroff R, Javle M, Raghav K, Kaseb A, Aloia TA, Vauthey JN, Tzeng CD, Herman JM, Koong AC, Krishnan SX, Minsky BD, Crane CH, Das P, Koay EJ.

Cancer Med. 2018 Oct;7(10):4880-4892. doi: 10.1002/cam4.1734. Epub 2018 Aug 27.

47.

Validation of American Joint Committee on Cancer eighth staging system for gallbladder cancer and its lymphadenectomy guidelines.

Lee AJ, Chiang YJ, Lee JE, Conrad C, Chun YS, Aloia TA, Vauthey JN, Tzeng CD.

J Surg Res. 2018 Oct;230:148-154. doi: 10.1016/j.jss.2018.04.067. Epub 2018 May 31.

PMID:
30100032
48.

What Is the Best Pain Control After Major Hepatopancreatobiliary Surgery?

Kim BJ, Soliz JM, Aloia TA, Vauthey JN.

Adv Surg. 2018 Sep;52(1):235-246. doi: 10.1016/j.yasu.2018.03.002. Epub 2018 Jun 19. Review. No abstract available.

49.

Surgical Resection for Recurrence After Two-Stage Hepatectomy for Colorectal Liver Metastases Is Feasible, Is Safe, and Improves Survival.

Lillemoe HA, Kawaguchi Y, Passot G, Karagkounis G, Simoneau E, You YN, Mehran RJ, Chun YS, Tzeng CD, Aloia TA, Vauthey JN.

J Gastrointest Surg. 2019 Jan;23(1):84-92. doi: 10.1007/s11605-018-3890-y. Epub 2018 Aug 6.

PMID:
30084064
50.

Reviewing the review: a qualitative assessment of the peer review process in surgical journals.

Davis CH, Bass BL, Behrns KE, Lillemoe KD, Garden OJ, Roh MS, Lee JE, Balch CM, Aloia TA.

Res Integr Peer Rev. 2018 May 23;3:4. doi: 10.1186/s41073-018-0048-0. eCollection 2018.

Supplemental Content

Support Center